RRAGB-mediated suppression of PI3K/AKT exerts anti-cancer role in glioblastoma
Biochemical and Biophysical Research Communications · 2023
DOI: 10.1016/j.bbrc.2023.07.031 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2023. Verfasst von Qinggang Li und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Peking University People's Hospital, No. 11, Xizhimen South Street, Xicheng District, Beijing, 100044, China; Department …. Hauptthemen laut MEDLINE: Glioblastoma, Brain Neoplasms, Glioma, Monomeric GTP-Binding Proteins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben.
Abstract (Originalsprache)
Glioblastoma (GBM) has a high degree of invasiveness, which is largely attributed to the invalidation of current therapy and the unclear tumor growth mechanism. Ras related GTP binding B (RRAGB) is a family member of the Ras-homologous GTPases. The effect of RRAGB on tumor growth has been recognized, but its influences on GBM progression are ill-defined. Here, in our research, a significantly decreased expression of RRAGB in GBM tissues by using TCGA databases and glioma samples is observed. According to Kaplan-Meier (KM) analysis, RRAGB low expression leads to a significant decrease of overall survival rate of patients, and is associated with the classification of WHO grade, histological type and age increase. Functional enrichment analysis reveals that the pathway of enrichment includes cell cycle arrest, extracellular matrix (ECM) processes and PI3K/AKT signal. Thereafter, our cell experiments confirm an obvious decrease of RRAGB in several GBM cell lines. It should be noted that RRAGB promotion strongly reduces the proliferation, migration and invasion of GBM cells and induces cell cycle arrest in G0/G1 phase. RRAGB up-regulation significantly decreases the expression of PI3K, phosphorylated AKT, mTOR and S6K in GBM cell lines. Surprisingly, we further find that RRAGB-restrained proliferative, migratory and invasive properties of GBM cells are markedly offset after promoting AKT activation, accompanied with restored phosphorylation of mTOR and S6K, elucidating that AKT signaling blockage is partially indispensable for RRAGB to play its anti-cancer role in GBM. Animal studies confirmed that RRAGB over-expression obviously inhibits the tumor growth both in the xenograft and orthotopic mouse glioma models, along with improved overall survival rates. In short, we provide evidence that RRAGB is a potential therapeutic target and prognostic marker for GBM treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurosurgery, Peking University People's Hospital, No. 11, Xizhimen South Street, Xicheng District, Beijing, 100044, China; Department of Neurosurgery, Beijing Beiya Orthopedic Hospital, No. 20, Haotian No…
- Sanmenxia Key Laboratory of Neurotumor Diagnosis and Treatment, Department of Neurosurgery, Sanmenxia Central Hospital, 472000, Sanmenxia, Henan, China.
- College of Basic Medicine and Forensic Medicine, Henan University of Science and Technology, Luoyang, 471000, China.
- Sanmenxia Key Laboratory of Neurotumor Diagnosis and Treatment, Department of Neurosurgery, Sanmenxia Central Hospital, 472000, Sanmenxia, Henan, China. Electronic address: fangdd_skldtnt@126.com.
Zitieren
APA
Li, Q., Liu, X., Mao, J., Liu, S., Hou, B., Li, K., & Fang, D. (2023). RRAGB-mediated suppression of PI3K/AKT exerts anti-cancer role in glioblastoma. Biochemical and Biophysical Research Communications. https://doi.org/10.1016/j.bbrc.2023.07.031
Vancouver
Li Q, Liu X, Mao J, Liu S, Hou B, Li K, et al. RRAGB-mediated suppression of PI3K/AKT exerts anti-cancer role in glioblastoma. Biochemical and Biophysical Research Communications. 2023. doi:10.1016/j.bbrc.2023.07.031
BibTeX
@article{Li2023,
author = {Li, Qinggang and Liu, Xiaonan and Mao, Jian and Liu, Shimin and Hou, Baosen and Li, Kaiyan and Fang, Dandong},
title = {RRAGB-mediated suppression of PI3K/AKT exerts anti-cancer role in glioblastoma},
journal = {Biochemical and Biophysical Research Communications},
year = {2023},
doi = {10.1016/j.bbrc.2023.07.031}
}
EUVIMED